Phase 3 N=60 Black Widow Spider Antivenin for Patients With Systemic Latrodectism
Latrodectism
Primary: Number of Participants With Treatment Failure — 15; 24 Participants — p=0.0185
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.